AZN - AstraZeneca will buy Fusion Pharmaceuticals for ~$2B
2024-03-19 04:10:27 ET
More on AstraZeneca & Fusion Pharmaceuticals
- 5 Reasons AstraZeneca Stock Can Rise In 2024
- Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook
- AstraZeneca to cap costs of inhalers at $35 per month
- AstraZeneca to expand rare disease pipeline with $1.05B Amolyt Pharma acquisition